Feraccru is a unique, non-salt, formulation oral iron: strong efficacy with “placebo-like” tolerability Potential to change iron deficiency anaemia (IDA) therapeutic algorithm Feraccru to become the preferred option for patients not adequately controlled or who are intolerant to generic oral iron sup
18 Jan 2019
Shield Therapeutics: Feraccru - a potential game changer in the treatment of iron deficiency anaemia
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Shield Therapeutics: Feraccru - a potential game changer in the treatment of iron deficiency anaemia
Shield Therapeutics Plc (STX:LON) | 1.5 0 (-3.7%) | Mkt Cap: 11.5m
- Published:
18 Jan 2019 -
Author:
Riccardo Lowi -
Pages:
15
Feraccru is a unique, non-salt, formulation oral iron: strong efficacy with “placebo-like” tolerability Potential to change iron deficiency anaemia (IDA) therapeutic algorithm Feraccru to become the preferred option for patients not adequately controlled or who are intolerant to generic oral iron sup